152 related articles for article (PubMed ID: 27916589)
1. A Novel Mechanism for Human Cardiac Ankyrin-B Syndrome due to Reciprocal Chromosomal Translocation.
Huq AJ; Pertile MD; Davis AM; Landon H; James PA; Kline CF; Vohra J; Mohler PJ; Delatycki MB
Heart Lung Circ; 2017 Jun; 26(6):612-618. PubMed ID: 27916589
[TBL] [Abstract][Full Text] [Related]
2. Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.
Mohler PJ; Le Scouarnec S; Denjoy I; Lowe JS; Guicheney P; Caron L; Driskell IM; Schott JJ; Norris K; Leenhardt A; Kim RB; Escande D; Roden DM
Circulation; 2007 Jan; 115(4):432-41. PubMed ID: 17242276
[TBL] [Abstract][Full Text] [Related]
3. Novel Variant in the
Swayne LA; Murphy NP; Asuri S; Chen L; Xu X; McIntosh S; Wang C; Lancione PJ; Roberts JD; Kerr C; Sanatani S; Sherwin E; Kline CF; Zhang M; Mohler PJ; Arbour LT
Circ Cardiovasc Genet; 2017 Jan; 10(1):. PubMed ID: 28196901
[TBL] [Abstract][Full Text] [Related]
4. Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease.
Cunha SR; Le Scouarnec S; Schott JJ; Mohler PJ
J Mol Cell Cardiol; 2008 Dec; 45(6):724-34. PubMed ID: 18790697
[TBL] [Abstract][Full Text] [Related]
5. Ankyrin-B syndrome: a case of sinus node dysfunction, atrial fibrillation and prolonged QT in a young adult.
Robaei D; Ford T; Ooi SY
Heart Lung Circ; 2015 Feb; 24(2):e31-4. PubMed ID: 25456501
[TBL] [Abstract][Full Text] [Related]
6. Common human ANK2 variant confers in vivo arrhythmia phenotypes.
Musa H; Murphy NP; Curran J; Higgins JD; Webb TR; Makara MA; Wright P; Lancione PJ; Lubbers ER; Healy JA; Smith SA; Bennett V; Hund TJ; Kline CF; Mohler PJ
Heart Rhythm; 2016 Sep; 13(9):1932-40. PubMed ID: 27298202
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and Alterations of Cardiac Ion Channels Leading to Disease: Role of Ankyrin-B in Cardiac Function.
Sucharski HC; Dudley EK; Keith CBR; El Refaey M; Koenig SN; Mohler PJ
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32023981
[TBL] [Abstract][Full Text] [Related]
8. Cardiac ankyrins in health and disease.
Hashemi SM; Hund TJ; Mohler PJ
J Mol Cell Cardiol; 2009 Aug; 47(2):203-9. PubMed ID: 19394342
[TBL] [Abstract][Full Text] [Related]
9. The evolving role of ankyrin-B in cardiovascular disease.
Koenig SN; Mohler PJ
Heart Rhythm; 2017 Dec; 14(12):1884-1889. PubMed ID: 28765088
[TBL] [Abstract][Full Text] [Related]
10. Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation.
Cunha SR; Hund TJ; Hashemi S; Voigt N; Li N; Wright P; Koval O; Li J; Gudmundsson H; Gumina RJ; Karck M; Schott JJ; Probst V; Le Marec H; Anderson ME; Dobrev D; Wehrens XH; Mohler PJ
Circulation; 2011 Sep; 124(11):1212-22. PubMed ID: 21859974
[TBL] [Abstract][Full Text] [Related]
11. Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting.
Mohler PJ; Bennett V
Curr Opin Cardiol; 2005 May; 20(3):189-93. PubMed ID: 15861006
[TBL] [Abstract][Full Text] [Related]
12. Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease.
Le Scouarnec S; Bhasin N; Vieyres C; Hund TJ; Cunha SR; Koval O; Marionneau C; Chen B; Wu Y; Demolombe S; Song LS; Le Marec H; Probst V; Schott JJ; Anderson ME; Mohler PJ
Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15617-22. PubMed ID: 18832177
[TBL] [Abstract][Full Text] [Related]
13. Ankyrins and human disease: what the electrophysiologist should know.
Mohler PJ
J Cardiovasc Electrophysiol; 2006 Oct; 17(10):1153-9. PubMed ID: 16800854
[TBL] [Abstract][Full Text] [Related]
14. Cardiac ankyrins: Essential components for development and maintenance of excitable membrane domains in heart.
Cunha SR; Mohler PJ
Cardiovasc Res; 2006 Jul; 71(1):22-9. PubMed ID: 16650839
[TBL] [Abstract][Full Text] [Related]
15. CaMKII inhibition rescues proarrhythmic phenotypes in the model of human ankyrin-B syndrome.
DeGrande S; Nixon D; Koval O; Curran JW; Wright P; Wang Q; Kashef F; Chiang D; Li N; Wehrens XH; Anderson ME; Hund TJ; Mohler PJ
Heart Rhythm; 2012 Dec; 9(12):2034-41. PubMed ID: 23059182
[TBL] [Abstract][Full Text] [Related]
16. Ankyrin-based targeting pathway regulates human sinoatrial node automaticity.
Hund TJ; Mohler PJ
Channels (Austin); 2008; 2(6):404-6. PubMed ID: 19098452
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation and sinus node dysfunction in human ankyrin-B syndrome: a computational analysis.
Wolf RM; Glynn P; Hashemi S; Zarei K; Mitchell CC; Anderson ME; Mohler PJ; Hund TJ
Am J Physiol Heart Circ Physiol; 2013 May; 304(9):H1253-66. PubMed ID: 23436330
[TBL] [Abstract][Full Text] [Related]
18. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.
Mohler PJ; Splawski I; Napolitano C; Bottelli G; Sharpe L; Timothy K; Priori SG; Keating MT; Bennett V
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9137-42. PubMed ID: 15178757
[TBL] [Abstract][Full Text] [Related]
19. Targeted mutational analysis of ankyrin-B in 541 consecutive, unrelated patients referred for long QT syndrome genetic testing and 200 healthy subjects.
Sherman J; Tester DJ; Ackerman MJ
Heart Rhythm; 2005 Nov; 2(11):1218-23. PubMed ID: 16253912
[TBL] [Abstract][Full Text] [Related]
20. Common genetic variants in ANK2 modulate QT interval: results from the KORA study.
Sedlacek K; Stark K; Cunha SR; Pfeufer A; Weber S; Berger I; Perz S; Kääb S; Wichmann HE; Mohler PJ; Hengstenberg C; Jeron A
Circ Cardiovasc Genet; 2008 Dec; 1(2):93-9. PubMed ID: 20031550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
